Testosterone therapy can help to restore the sexual function of men with hypogonadism, increasing their energy levels and restoring their libido. This often leads to higher levels of enjoyment in life. Additionally, physical changes can increase the confidence of patients on testosterone therapy - often, muscle mass increases and men feel more 'normal' again.
Testosterone, historically believed to be important only for male sexual function, has over the past decades transformed from niche hormone to multi-system player.23 There is increasing recognition of the harmful consequences of hypogonadism (also known as testosterone deficiency) and the wide spectrum beneficial health effects of testosterone therapy.24,25
A growing number of studies have provided evidence that it takes several years for many of the beneficial health effects of testosterone therapy to manifest fully26, and that for most men maintenance of these health benefits requires lifelong testosterone therapy, as explained in the FAQ section.
Sexual dysfunction and low libido are among the most easily reversible symptoms of hypogonadism. Systematic reviews of randomized, placebo-controlled clinical trials of testosterone in men, including older men (aged 60 years and over) and middle-aged men, with sexual dysfunction and hypogonadism have shown large favourable effects on libido and moderate effects on satisfaction with erectile function.1-5 In men who do not respond sufficiently to testosterone therapy alone, the combination of phosphodiesterase 5-inhibitors and testosterone may be indicated, as there are suggestions that the combination may be synergistic.1
Alterations in mood and depression are a symptom of, but not confined to, hypogonadism.1,6 Outcomes in clinical trials of the effect of testosterone treatment on mood have varied. However, there is evidence that testosterone treatment results in improvements in mood, particularly in older men with hypogonadism.7,8 Similarly, although there is an established association between measures of cognitive ability and serum levels of testosterone, the benefits of testosterone treatment on cognition are less clearly established, with some studies reporting improvements in some measures of cognitive function and others failing to detect benefits.6,9-11 Although a potential role for testosterone in protecting cognitive function and preventing Alzheimer’s disease has been proposed by some researchers, confirmation from appropriately-designed clinical trials is awaited.
Testosterone therapy improves body composition (increase in lean body mass, decrease in fat mass) in men with hypogonadism.1 There is a supplementary improvement in muscle strength and physical function. The benefits of testosterone treatment on body composition have consistently been demonstrated in clinical studies of testosterone therapy in hypogonadal men or men with borderline low testosterone levels,1,6,8,12,13and confirmed by systematic reviews or meta-analyses of randomized controlled trials.4,5,6,13
Hypogonadism is highly prevalent amongst men with diabetes mellitus type 2 or symptoms of the metabolic syndrome, including insulin resistance, impaired glucose regulation, obesity, and hypertension.1,6,13,14,18,19 Low testosterone in many men with diabetes remains undiagnosed and untreated, and current guidelines recommend measurement of testosterone levels in such patients and, equally, that such chronic diseases should be investigated and treated in men with hypogonadism.1,6 It is not yet fully known whether diabetes is a cause or a consequence of low testosterone, and the full effects of testosterone administration on glycemic control in hypogonadal men with diabetes are unclear. However, there are indications that treating hypogonadism may have benefits on metabolic status in men with diabetes, and there is evidence that testosterone therapy has a beneficial effect on risk factors for diabetes such as central obesity, insulin sensitivity, glucose control and blood lipid profiles in hypogonadal men with type 2 diabetes.14,20,21
A large number of trials have shown the positive effects of testosterone treatment on markers of bone formation and increased bone density in hypogonadal men treated with testosterone.1,4,6,8,13 Not surprisingly, the effects may take several years to fully develop. At present no data on the role of testosterone in preventing fracture in men with hypogonadism are available.
In fact, there is increasing evidence of the potential benefits of testosterone therapy on multiple cardiovascular risk factors. This evidence has been comprehensively reviewed by Traish et al. in the Journal of Andrology.16 Although the full effects of testosterone therapy on cardiovascular risk are yet to be established, the balance of emerging evidence from clinical studies suggests that testosterone therapy in hypogonadal men may improve endothelial function, reduce proinflammatory factors, reduce hypertension, and improve the lipid profile17.